2019
DOI: 10.1038/s41569-019-0220-3
|View full text |Cite
|
Sign up to set email alerts
|

G protein-coupled receptor kinases as therapeutic targets in the heart

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
72
0
1

Year Published

2019
2019
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 100 publications
(82 citation statements)
references
References 162 publications
0
72
0
1
Order By: Relevance
“…GRKs are identified as key players in the desensitization and internalization of multiple GPCRs. The role of GRKs-induced GPCRs excessive desensitization in heart failure was extensively described [14]. Excessive desensitization of β-adrenergic receptors mediated by GRK2 resulted in a loss of cardiomyocyte contractile reserve.…”
Section: Introductionmentioning
confidence: 99%
“…GRKs are identified as key players in the desensitization and internalization of multiple GPCRs. The role of GRKs-induced GPCRs excessive desensitization in heart failure was extensively described [14]. Excessive desensitization of β-adrenergic receptors mediated by GRK2 resulted in a loss of cardiomyocyte contractile reserve.…”
Section: Introductionmentioning
confidence: 99%
“…Since GRK2 has been discovered to be responsible for GPCRs desensitization and down-regulation of GPCRs signaling. 33 Therefore, we speculate that low expression of GRK2 may promote HCC invasion and metastasis by inhibiting EP2 desensitization thus increasing its expression in the cell membranes. Tumor metastasis constitutes one of the most significant biological characteristics of malignant tumors and the leading cause of death in clinical cancer patients.…”
Section: Discussionmentioning
confidence: 91%
“…In the past two decades, GRKs have been shown to play an important role in the heart by regulating GPCR signaling. Changes in GRK expression have been linked to many cardiovascular pathologies, including myocardial infarction, hypertension, and cardiac hypertrophy [90]. Therefore, GRKs have been extensively studied as therapeutic targets in cardiovascular disease.…”
Section: Antiplatelet Drugs Targeting At Gpcrs and Their Regulatorsmentioning
confidence: 99%